Toxicological effects of Caco-2 cells following short-term and long-term exposure to Ag nanoparticles

International Journal of Molecular Sciences

Volumn 17, Issue 6, 2016, Pages

  Chen, Ni ^a   Song, Zheng Mei ^a   Tang, Huan ^b   Xi, Wen Song ^a   Cao, Aoneng ^a   Liu, Yuanfang ^a,b   Wang, Haifang ^a  

^a SHANGHAI UNIVERSITY   (China)

^b PEKING UNIVERSITY   (China)

Author keywords

Ag nanoparticle; Caco 2 cells; Long term; Low dose; Surface coating; Toxicity

Indexed keywords

INTERLEUKIN 8; LIPOCORTIN 5; SILVER NANOPARTICLE; 2 PYRROLIDONE DERIVATIVE; CITRIC ACID; METAL NANOPARTICLE; POLYVINYL DERIVATIVE; REACTIVE OXYGEN METABOLITE; SILVER;

APOPTOSIS; ARTICLE; CACO 2 CELL LINE; CELL CYCLE ASSAY; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG EXPOSURE; GROWTH INHIBITION; HUMAN; HUMAN CELL; LONG TERM EXPOSURE; MEMBRANE POTENTIAL; MITOCHONDRIAL BIOGENESIS; NONHUMAN; OPTICAL DENSITY; THERMOGRAVIMETRY; TRANSMISSION ELECTRON MICROSCOPY; CACO-2 CELL LINE; CHEMISTRY; DRUG EFFECTS; METABOLISM; MITOCHONDRION;

APOPTOSIS; CACO-2 CELLS; CITRATES; HUMANS; METAL NANOPARTICLES; MITOCHONDRIA; POLYVINYLS; PYRROLIDINONES; REACTIVE OXYGEN SPECIES; SILVER;

EID: 84975864714     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms17060974     Document Type: Article

References (39)

1. Nowack, B.; Krug, H.F.; Height, M. 120 years of nanosilver history: Implications for policy makers. Environ. Sci. Technol. 2011, 45, 1177-1183.[CrossRef] [PubMed]
2. Matzke, M.; Jurkschat, K.; Backhaus, T. Toxicity of differently sized and coated silver nanoparticles to the bacterium Pseudomonas putida: Risks for the aquatic environment? Ecotoxicology 2014, 23, 818-829.[CrossRef] [PubMed]
3. Hendren, C.O.; Mesnard, X.; Droge, J.; Wiesner, M.R. Estimating production data for five engineered nanomaterials as a basis for exposure assessment. Environ. Sci. Technol. 2011, 45, 2562-2569.[CrossRef] [PubMed]
4. Quadros, M.E.; Marr, L.C. Environmental and human health risks of aerosolized silver nanoparticles. J. Air Waste Manag. Assoc. 2010, 60, 770-781.[CrossRef] [PubMed]
5. Kreyling, W.G.; Semmler-Behnke, M.; Takenaka, S.; Moller, W. Differences in the biokinetics of inhaled nano-versus micrometer-sized particles. Acc. Chem. Res. 2013, 46, 714-722.[CrossRef] [PubMed]
6. Jiang, X.; Miclaus, T.; Wang, L.; Foldbjerg, R.; Sutherland, D.S.; Autrup, H.; Chen, C.; Beer, C. Fast intracellular dissolution and persistent cellular uptake of silver nanoparticles in CHO-K1 cells: Implication for cytotoxicity. Nanotoxicology 2015, 9, 181-189.[CrossRef] [PubMed]
7. Kim, Y.-J.; Yang, S.I.; Ryu, J.-C. Cytotoxicity and genotoxicity of nano-silver in mammalian cell lines. Mol. Cell Toxicol. 2010, 6, 119-125.[CrossRef]
8. Hamilton, R.F., Jr.; Buckingham, S.; Holian, A. The effect of size on Ag nanosphere toxicity in macrophage cell models and lung epithelial cell lines is dependent on particle dissolution. Int. J. Mol. Sci. 2014, 15, 6815-6830.[CrossRef] [PubMed]
9. Dubey, P.; Matai, I.; Kumar, S.U.; Sachdev, A.; Bhushan, B.; Gopinath, P. Perturbation of cellular mechanistic system by silver nanoparticle toxicity: Cytotoxic, genotoxic and epigenetic potentials. Adv. Colloid Interface Sci. 2015, 221, 4-21.[CrossRef] [PubMed]
10. Song, Y.J.; Guan, R.; Lyu, F.; Kang, T.; Wu, Y.; Chen, X. In vitro cytotoxicity of silver nanoparticles and zinc oxide nanoparticles to human epithelial colorectal adenocarcinoma (Caco-2) cells. Mutat. Res. Fund. Mol. Mech. 2014, 769, 113-118.[CrossRef] [PubMed]
11. Aueviriyavit, S.; Phummiratch, D.; Maniratanachote, R. Mechanistic study on the biological effects of silver and gold nanoparticles in Caco-2 cells-Induction of the Nrf2/HO-1 pathway by high concentrations of silver nanoparticles. Toxicol. Lett. 2014, 224, 73-83.[CrossRef] [PubMed]
12. Cheung, T.S.; Lau, P.M.; Lu, H.; Ho, H.P.; Lui, P.P.Y.; Kong, S.K. Cytotoxic and sublethal effects of silver nanoparticles on tendon-derived stem cells—Implications for tendon engineering. Toxicol. Res. 2016, 5, 318-330.[CrossRef]
13. Comfort, K.K.; Braydich-Stolle, L.K.; Maurer, E.I.; Hussain, S.M. Less is more: Long-term in vitro exposure to low levels of silver nanoparticles provides new insights for nanomaterial evaluation. ACS Nano 2014, 8, 3260-3271.[CrossRef] [PubMed]
14. Coccini, T.; Manzo, L.; Bellotti, V.; Simone, U.D. Assessment of cellular responses after short- and long-term exposure to silver nanoparticles in human neuroblastoma (SH-SY5Y) and astrocytoma (D384) cells. Sci. World J. 2014, 259765.[CrossRef] [PubMed]
15. Vales, G.; Rubio, L.; Marcos, R. Long-term exposures to low doses of titanium dioxide nanoparticles induce cell transformation, but not genotoxic damage in BEAS-2B cells. Nanotoxicology 2015, 9, 568-578.[CrossRef] [PubMed]
16. Aude-Garcia, C.; Villiers, F.; Collin-Faure, V.; Pernet-Gallay, K.; Jouneau, P.-H.; Sorieul, S.; Mure, G.; Gerdil, A.; Herlin-Boime, N.; Carrière, M. et al. Different in vitro exposure regimens of murine primary macrophages to silver nanoparticles induce different fates of nanoparticles and different toxicological and functional consequences. Nanotoxicology 2016, 10, 586-596.[CrossRef] [PubMed]
17. Hristozov, D.R.; Gottardo, S.; Critto, A.; Marcomini, A. Risk assessment of engineered nanomaterials: A review of available data and approaches from a regulatory perspective. Nanotoxicology 2012, 6, 880-898.[CrossRef] [PubMed]
18. Tarantini, A.; Lanceleur, R.; Mourot, A.; Lavault, M.-T.; Casterou, G.; Jarry, G.; Hogeveen, K.; Fessard, V. Toxicity, genotoxicity and proinflammatory effects of amorphous nanosilica in the human intestinal Caco-2 cell line. Toxicol. Vitr. 2015, 29, 398-407.[CrossRef] [PubMed]
19. 2 rutile/anatase mixed phase nanoparticles on Caco-2 cells. Chem. Res. Toxicol. 2012, 25, 646-655.[CrossRef] [PubMed]
20. Chalew, A.T.E.; Schwab, K.J. Toxicity of commercially available engineered nanoparticles to Caco-2 and SW480 human intestinal epithelial cells. Cell Biol. Toxicol. 2013, 29, 101-116.[CrossRef] [PubMed]
21. Miethling-Graff, R.; Rumpker, R.; Richter, M.; Verano-Braga, T.; Kjeldsen, F.; Brewer, J.; Hoyland, J.; Rubahn, H.-G.; Erdmann, H. Exposure to silver nanoparticles induces size- and dose-dependent oxidative stress and cytotoxicity in human colon carcinoma cells. Toxicol. Vitr. 2014, 28, 1280-1289.[CrossRef] [PubMed]
22. Foldbjerg, R.; Jiang, X.; Miclaus, T.; Chen, C.; Autrup, H.; Beer, C. Silver nanoparticles—Wolves in sheep’s clothing? Toxicol. Res. 2015, 4, 563-575.[CrossRef]
23. + cancer cells. RSC Adv. 2015, 5, 43733-43740.[CrossRef]
24. 60 aggregates changing the mitochondrial membrane potential. Environ. Toxicol. Pharm. 2015, 39, 237-246.[CrossRef] [PubMed]
25. 2 nanoparticles. Small 2010, 6, 1908-1917.[CrossRef] [PubMed]
26. Wang, J.; Sun, P.; Bao, Y.; Liu, J.; An, L. Cytotoxicity of single-walled carbon nanotubes on PC12 cells. Toxicol. Vitr. 2011, 25, 242-250.[CrossRef] [PubMed]
27. ISO 10993-5:2009. Biological Evaluation of Medical Devices—Part 5: Tests for in Vitro Cytotoxicity. Standardization IOf ed. vol. ISO 10993-5. Switzerland; 2009. Available online: http://www.instrument.com.cn/download/shtml/436871.shtml (accessed on 8 May 2016).
28. The Woodrow Wilson Inventory. Available online: http://www.nanotechproject.org (accessed on 12 February 2016).
29. Ahameda, M.; Karnsa, M.; Goodsona, M.; Rowea, J.; Hussainb, S.M.; Schlagerb, J.J.; Honga, Y. DNA damage response to different surface chemistry of silver nanoparticles in mammalian cells. Toxicol. Appl. Pharm. 2008, 233, 404-410.[CrossRef] [PubMed]
30. Yang, C.; Uertz, J.; Yohan, D.; Chithrani, B.D. Peptide modified gold nanoparticles for improved cellular uptake, nuclear transport, and intracellular retention. Nanoscale 2014, 6, 12026-12033.[CrossRef] [PubMed]
31. Gliga, A.R.; Skoglund, S.; Wallinder, I.O.; Fadeel, B.; Karlsson, H.L. Size-dependent cytotoxicity of silver nanoparticles in human lung cells: The role of cellular uptake, agglomeration and Ag release. Part. Fibre Toxicol. 2014, 11, 11.[CrossRef] [PubMed]
32. Wei, L.; Lu, J.; Xu, H.; Patel, A.; Chen, Z.-S.; Chen, G. Silver nanoparticles: Synthesis, properties, and therapeutic applications. Drug Discov. Today 2015, 20, 595-601.[CrossRef] [PubMed]
33. Böhmert, L.; Niemann, B.; Thünemann, A.F.; Lampen, A. Cytotoxicity of peptide-coated silver nanoparticles on the human intestinal cell line Caco-2. Arch. Toxicol. 2012, 86, 1107-1115.[CrossRef] [PubMed]
34. Mtirosyan, A.; Bazes, A.; Schneider, Y.J. In vitro toxicity assessment of silver nanoparticles in the presence of phenolic compounds-preventive agents against the harmful effect? Nanotoxicology 2014, 8, 573-582.[CrossRef] [PubMed]
35. Stensberg, M.C.; Wei, Q.; McLamore, E.S.; Porterfield, D.M.; Wei, A.; Sepúlveda, M.S. Toxicological studies on silver nanoparticles: Challenges and opportunities in assessment, monitoring and imaging. Nanomedicine 2011, 6, 879-898.[CrossRef] [PubMed]
36. Kim, S.; Choi, J.E.; Choi, J.; Chung, K.-H.; Park, K.; Yi, J.; Ryua, D.-Y. Oxidative stress-dependent toxicity of silver nanoparticles in human hepatoma cells. Toxicol. Vitr. 2009, 23, 1076-1084.[CrossRef] [PubMed]
37. Vlahopoulos, S.; Boldogh, I.; Casola, A.; Brasier, A.R. Nuclear factor-κB-dependent induction of interleukin-8 gene expression by tumor necrosis factor α: Evidence for an antioxidant sensitive activating pathway distinct from nuclear translocation. Blood 1999, 94, 1878-1889.[PubMed]
38. Xu, Y.; Tang, H.; Wang, H.; Liu, Y. Blockade of oral tolerance to ovalbumin in mice by silver nanoparticles. Nanomedicine 2015, 10, 419-431.[CrossRef] [PubMed]
39. Song, Z.-M.; Chen, N.; Liu, J.-H.; Tang, H.; Deng, X.; Xi, W.-S.; Han, K.; Cao, A.; Liu, Y.; Wang, H. Biological effect of food additive titanium dioxide nanoparticles on intestine: An in vitro study. J. Appl. Toxicol. 2015, 35, 1169-1178.[CrossRef] [PubMed]